Bionik Laboratories Corp Stock Price Prediction
As of now the relative strength index (rsi) of Bionik Laboratories' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Bionik Laboratories' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bionik Laboratories and does not consider all of the tangible or intangible factors available from Bionik Laboratories' fundamental data. We analyze noise-free headlines and recent hype associated with Bionik Laboratories Corp, which may create opportunities for some arbitrage if properly timed.
Check out Bionik Laboratories Basic Forecasting Models to cross-verify your projections.
Oversold Vs Overbought
0
Oversold | Overbought |
Using Bionik Laboratories hype-based prediction, you can estimate the value of Bionik Laboratories Corp from the perspective of Bionik Laboratories response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bionik Laboratories to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bionik because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bionik Laboratories after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bionik |
Bionik Laboratories After-Hype Price Prediction Density Analysis
As far as predicting the price of Bionik Laboratories at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bionik Laboratories or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bionik Laboratories, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bionik Laboratories Estimiated After-Hype Price Volatility
In the context of predicting Bionik Laboratories' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bionik Laboratories' historical news coverage. Bionik Laboratories' after-hype downside and upside margins for the prediction period are 0.00 and 12.70, respectively. We have considered Bionik Laboratories' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bionik Laboratories is out of control at this time. Analysis and calculation of next after-hype price of Bionik Laboratories Corp is based on 3 months time horizon.
Bionik Laboratories Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bionik Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bionik Laboratories backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bionik Laboratories, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.61 | 12.70 | 0.00 | 0.59 | 0 Events / Month | 5 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Bionik Laboratories Hype Timeline
Bionik Laboratories Corp is currently traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.59. Bionik is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -1.61%. %. The volatility of related hype on Bionik Laboratories is about 3479.45%, with the expected price after the next announcement by competition of 0.59. About 62.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.78. Bionik Laboratories Corp last dividend was issued on the 30th of October 2018. The entity had 1:150 split on the 30th of October 2018. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Bionik Laboratories Basic Forecasting Models to cross-verify your projections.Bionik Laboratories Related Hype Analysis
Having access to credible news sources related to Bionik Laboratories' direct competition is more important than ever and may enhance your ability to predict Bionik Laboratories' future price movements. Getting to know how Bionik Laboratories' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bionik Laboratories may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RZLT | Rezolute | (0.28) | 7 per month | 3.08 | 0.03 | 6.81 | (5.54) | 30.01 | |
| TPST | Tempest Therapeutics | (0.09) | 4 per month | 0.00 | (0.13) | 6.38 | (8.53) | 29.55 | |
| FBRX | Forte Biosciences | 3.09 | 5 per month | 3.41 | 0.11 | 6.65 | (6.33) | 126.20 | |
| DYAI | Dyadic International | (0.03) | 7 per month | 3.66 | 0.08 | 9.00 | (7.20) | 16.89 | |
| DMAC | DiaMedica Therapeutics | 0.19 | 6 per month | 2.11 | 0.04 | 4.94 | (3.29) | 10.25 | |
| SILO | Silo Pharma | 0.00 | 0 per month | 0.00 | (0.15) | 6.31 | (10.57) | 23.28 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 5.04 | (0.01) | 9.61 | (8.53) | 52.92 | |
| MLYS | Mineralys Therapeutics, Common | 0.14 | 8 per month | 3.42 | 0.02 | 6.27 | (5.79) | 20.98 |
Bionik Laboratories Additional Predictive Modules
Most predictive techniques to examine Bionik price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bionik using various technical indicators. When you analyze Bionik charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bionik Laboratories Predictive Indicators
The successful prediction of Bionik Laboratories stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bionik Laboratories Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bionik Laboratories based on analysis of Bionik Laboratories hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bionik Laboratories's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bionik Laboratories's related companies.
Story Coverage note for Bionik Laboratories
The number of cover stories for Bionik Laboratories depends on current market conditions and Bionik Laboratories' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bionik Laboratories is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bionik Laboratories' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Bionik Laboratories Short Properties
Bionik Laboratories' future price predictability will typically decrease when Bionik Laboratories' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bionik Laboratories Corp often depends not only on the future outlook of the potential Bionik Laboratories' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bionik Laboratories' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.8 M | |
| Cash And Short Term Investments | 2 M |
Other Information on Investing in Bionik Pink Sheet
Bionik Laboratories financial ratios help investors to determine whether Bionik Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bionik with respect to the benefits of owning Bionik Laboratories security.